Skip to main content

Day: March 22, 2021

PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs

RALEIGH, N.C., March 22, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today the launch of its Patient-Centric Trial Development Toolkit, available now to clinical development sponsors focusing on rare diseases. Developed by PRA’s Center for Rare Diseases in collaboration with PRA’s Rare Disease Advisory Committee (RDAC) and other patient stakeholders, the toolkit includes four digital resources designed to mitigate risks that frequently occur in rare disease clinical trials. The toolkit also introduces and affirms new patient-centric practices that promote trial participation. The Patient-Centric Trial Development Toolkit is available at no cost and can be downloaded at https://prahs.com/insights/patient-centric-trial-development-toolkit. “The main purpose of the toolkit is to guide sponsors in taking a more...

Continue reading

Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C

— 33% of patients treated with efruxifermin (EFX) (4 of 12) improved by one fibrosis stage without worsening of NASH — — 25% of EFX patients (3 of 12) showed NASH resolution — — Rapid fibrosis improvement in cirrhotic patients after only 16 weeks of EFX treatment, the highest rate reported publicly to date, suggests direct anti-fibrotic effects — SOUTH SAN FRANCISCO, Calif., March 22, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH), today announced results of an expansion cohort of a 16-week Phase 2a clinical trial, Cohort C, evaluating efruxifermin (EFX) in the treatment of adult patients with cirrhotic nonalcoholic steatohepatitis (NASH) (compensated stage...

Continue reading

Roche provides update on tominersen programme in manifest Huntington’s disease

Dosing to stop in Phase III clinical study of tominersen following recommendation from an Independent Data Monitoring Committee (iDMC) No new safety signals were identified for tominersen in the iDMC’s review             Basel, 22 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the decision to discontinue dosing in the Phase III GENERATION HD1 study of tominersen in manifest Huntington’s disease (HD). The decision was based on the results of a pre-planned review of the data from the Phase III study conducted by an unblinded Independent Data Monitoring Committee (iDMC). The iDMC made its recommendation based on the investigational therapy’s potential benefit/risk profile for study participants. No new or emerging safety signals were identified for tominersen in the review of the data from this study. Roche intends...

Continue reading

Hollard Goes Live in Australia with New Core Systems in Just Six Months

BOSTON and SYDNEY, March 22, 2021 (GLOBE NEWSWIRE) — Duck Creek Technologies (NASDAQ: DCT) and Xceedance announced today that global insurer Hollard has gone live in Australia with a new platform to administer personal motor, landlord, and home insurance lines backed by Duck Creek’s Policy, Billing, and Data Hub solutions. After the insurer was appointed to underwrite three personal lines products for a major insurance broker network, Hollard had to integrate the portfolio into its newly acquired technology. A successful transition to the broker network’s platform was achieved through a unique relationship between Hollard, Duck Creek, and systems integration partner Xceedance. The implementation was executed in just six months during the pandemic, thanks to the flexibility and low-code configuration of the Duck Creek Platform. With...

Continue reading

Purebase Receives Additional Funding from Existing Shareholder

IONE, CA, March 22, 2021 (GLOBE NEWSWIRE) — Purebase Corporation (OTCQB:PUBC), (“Purebase” or the “Company”), a diversified resource company, headquartered in Ione, California, announced today that it has received an additional financing commitment of up to $2,000,000 from its largest shareholder, US Mine Corp. (“USMC”), a privately held mining and exploration company, of which certain owners also serve on the Company’s board of directors.  US Mine Corp. has committed to funding Purebase on an as-needed basis through the issuance of unsecured convertible promissory notes. The notes will be payable 2-years after the date of issuance and have an interest rate of 5.0% per annum. US Mine Corp. will have the right to convert any amounts due under the notes into shares of Purebase’s common stock at a conversion price of $0.088 per share.               In...

Continue reading

Ændret finanskalender

Nasdaq First North Growth Market DenmarkSelskabsmeddelelse nr. 29/2021                                                                                    Odense, 22. marts 2021 Ændret finanskalender I henhold til finanskalenderen for 2021 skulle selskabets årsrapport for 2020 offentliggøres den 23. marts 2021.Udarbejdelsen af årsrapporten har taget længere tid end forventet og er endnu ikke klar.Årsrapporten for 2021 vil i stedet blive offentligjort den 14. april 2021. Om Scape TechnologiesScape Technologies, stiftet i 2004, er en fokuseret robotteknologisk virksomhed, der har udviklet den unikke binpicking løsning, SCAPE Bin-Picker. SCAPE Bin-Picker systemerne sælges i samarbejde med system-integratorer, der har ansvar for at opbygge og indkøre systemerne i kundernes produktionsapparat. I forbindelse med indkøring af binpicker systemerne...

Continue reading

Årsrapport for 2020 – Selskabsmeddelelse nr. 7/2021

København, 22. marts 2021 BEDRE END FORVENTEDE RESULTATER FOR ÅRET Hovedpunkter for 2020Resultat for året på DKK 4,5 mio. Totale pengestrømme for året på DKK 12,7 mio. Likvide midler pr. 31. december 2020 på DKK 21 mio., heraf DKK 17,2 mio. i moderselskabet EAC Invest, DKK 2,0 mio. i Thailand og DKK 1,8 mio. indestår i Kina og er ikke til umiddelbar disposition for EAC Invest koncernen, og derfor klassificeret som bundne likvider. Frasalg af Zhongbao Drinking Water indbringer et provenu på DKK 2,9 mio., og en gevinst på DKK 1 mio. Udbytte fra minoritetsinvesteringer på niveau med forventninger på DKK 1,9 mio. Aktiv involvering i Thai Poly Acrylic Co. Ltd. resulterede i et effektivt turnaround i 2020 og resultater betydeligt over forventning. Det planlagte omvendte aktiesplit og kapitalnedsættelsen blev gennemført ved aktietilbagekøb...

Continue reading

Class 1 Nickel Set to Commence Phase 1 Drill Program to Expand Mineral Resources at Alexo-Dundonald Project near Timmins

5000 m Phase 1 drilling program set to commence at Alexo North and South Deposits to expand current Mineral Resources Initial 25 drill holes designed to define the mineralized trends at Alexo South and Alexo North Approvals in place, drill rig operator hired, on-site technical team secured First part of 10,000 m Phase 1 program planned for the Alexo-Dundonald Project Company well funded to complete the Phase 1 program with existing treasuryTORONTO, March 22, 2021 (GLOBE NEWSWIRE) — Class 1 Nickel and Technologies Ltd. (CSE: NICO/OTCQB: NICLF) (“Class 1 Nickel” or the “Company”) is pleased to announce that all necessary approvals have been granted and all contractors secured in order to commence a Phase 1 drill program in April 2021 at Alexo Dundonald Nickel-Copper-Cobalt Project (“Alexo-Dundonald Project”),...

Continue reading

SAS Selects Willis Lease’s New Revolving Credit Lease Engine Financing Product for CFM LEAP and Trent XWB Engines

COCONUT CREEK, Fla., March 22, 2021 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) today announced it has closed its first transaction utilizing its new revolving credit lease engine financing product (the “RCL”). Scandinavian Airlines System (“SAS”) selected the RCL to finance CFM LEAP and Trent XWB engines, which power SAS’s A320neo and Airbus A350 aircraft, respectively. Willis Lease created the RCL to address a lack of financing options for new technology engines, despite the pricing of certain engine types approaching the pricing of a whole aircraft. The RCL marries certain attributes of a revolving loan with those of a traditional operating lease into one lease product with payment cash flows that mirror the way engines produce revenue for airlines. The RCL provides more liquidity, including for future...

Continue reading

Hollywall Entertainment Inc. (OTC: HWAL) Capitalizing on 5G Telecom Infrastructure Growth to Expand Broadband Availability

5G technology is faster than 4G with speeds of 20Gbps and 1ms latency The 5G infrastructure would assist Hollywall in the advancement of broadband, especially to rural and minority communities The FCC has provided a new internet subsidy program to credit internet bills to keep families connected through a $3.2 billion federal initiative bill The global 5G infrastructure market was valued at $9.77 billion in 2019 and is expected to grow at a CAGR of 29% through 2026WASHINGTON, March 22, 2021 (GLOBE NEWSWIRE) — via InvestorWire – The 5G network has been steadily working its way into existence for a couple of years now, with virtually all major telecommunications providers embracing the new technology. AT&T launched a small, low-band network in November 2019, followed by T-Mobile’s 5G Nationwide 600 MHz network. They followed...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.